Inventor
DUXIN SUN
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
A61KPreparations for medical, dental or toiletry purposes20%
B82YSpecific uses or applications of nanostructures13%
C07DHeterocyclic compounds13%
A61BDiagnosis7%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%
C07HSugars7%
G01NInvestigating or analysing materials by determining their chemical or physical properties7%
PatentTitleYear
12,516,080Remdesivir and remdesivir analogs, solutions, and nanoparticle, liposomal, and microparticle compositions for treating viral infections202612,226,491Nano-satellite complexes2025RE049687Thienopyrimidine and thienopyridine compounds and methods of use thereof202311,701,433Complexes for delivery of antigenic peptides202311,647,959Sampling device for drug development and diagnosis of gastric-intestinal diseases2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2026Patents assigned to UNIV MICHIGAN REGENTS (5)· patent assignee history
2023Patents assigned to KURA ONCOLOGY INC (1)· patent assignee history
2023–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV MICHIGAN REGENTS | 5 | 2023–2026 |
| KURA ONCOLOGY INC | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2023–2026 |